Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.

Lemiale F, Haddada H, Nabel GJ, Brough DE, King CR, Gall JG.

Vaccine. 2007 Mar 1;25(11):2074-84. Epub 2006 Nov 28.

2.

P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.

Vayssade M, Haddada H, Faridoni-Laurens L, Tourpin S, Valent A, Bénard J, Ahomadegbe JC.

Int J Cancer. 2005 Oct 10;116(6):860-9.

3.

p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection.

Terrasson J, Allart S, Martin H, Lulé J, Haddada H, Caput D, Davrinche C.

Cancer Res. 2005 Apr 1;65(7):2787-94.

4.

The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.

Goldschneider D, Million K, Meiller A, Haddada H, Puisieux A, Bénard J, May E, Douc-Rasy S.

J Cell Sci. 2005 Mar 15;118(Pt 6):1245-53. Epub 2005 Mar 1.

5.

In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas.

Robe PA, Bentires-Alj M, Bonif M, Rogister B, Deprez M, Haddada H, Khac MT, Jolois O, Erkmen K, Merville MP, Black PM, Bours V.

Clin Cancer Res. 2004 Aug 15;10(16):5595-603.

6.

Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.

Goldschneider D, Blanc E, Raguénez G, Barrois M, Legrand A, Le Roux G, Haddada H, Bénard J, Douc-Rasy S.

J Cell Sci. 2004 Jan 15;117(Pt 2):293-301.

7.
8.

When p53 needs p73 to be functional - forced p73 expression induces nuclear accumulation of endogenous p53 protein.

Goldschneider D, Blanc E, Raguenez G, Haddada H, Bénard J, Douc-Rasy S.

Cancer Lett. 2003 Jul 18;197(1-2):99-103. Review.

PMID:
12880967
9.

Potentiation of a tumor cell susceptibility to autologous CTL killing by restoration of wild-type p53 function.

Thiery J, Dorothée G, Haddada H, Echchakir H, Richon C, Stancou R, Vergnon I, Benard J, Mami-Chouaib F, Chouaib S.

J Immunol. 2003 Jun 15;170(12):5919-26.

10.

Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon gamma.

Cordier Kellerman L, Valeyrie L, Fernandez N, Opolon P, Sabourin JC, Maubec E, Le Roy P, Kane A, Legrand A, Abina MA, Descamps V, Haddada H.

Cancer Gene Ther. 2003 Jun;10(6):481-90.

PMID:
12768194
11.

Role of p53 in the sensitization of tumor cells to apoptotic cell death.

Thiery J, Echchakir H, Dorothée G, Ameyar-Zazoua M, Haddada H, Mami-Chouaib F, Chouaib S.

Mol Immunol. 2002 May;38(12-13):977-80.

PMID:
12009576
12.

Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: role of caspase-8 and mitochondria.

Ameyar-Zazoua M, Larochette N, Dorothée G, Daugas E, Haddada H, Gouloumet V, Métivier D, Stancou R, Mami-Chouaib F, Kroemer G, Chouaib S.

Cancer Gene Ther. 2002 Mar;9(3):219-27.

13.

Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-gamma delivery is associated with macrophages recruitment and nitric oxide production.

Baratin M, Ziol M, Romieu R, Kayibanda M, Gouilleux F, Briand P, Leroy P, Haddada H, Rénia L, Viguier M, Guillet JG.

Cancer Gene Ther. 2001 Mar;8(3):193-202.

14.

Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery.

Logeart D, Hatem SN, Rücker-Martin C, Chossat N, Névo N, Haddada H, Heimburger M, Perricaudet M, Mercadier JJ.

Hum Gene Ther. 2000 May 1;11(7):1015-22.

PMID:
10811230
15.

p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line.

Badie C, Bourhis J, Sobczak-Thépot J, Haddada H, Chiron M, Janicot M, Janot F, Tursz T, Vassal G.

Br J Cancer. 2000 Feb;82(3):642-50.

16.

Adenovirus-mediated wild-type-p53-gene expression sensitizes TNF-resistant tumor cells to TNF-induced cytotoxicity by altering the cellular redox state.

Shatrov VA, Ameyar M, Bouquet C, Cai Z, Stancou R, Haddada H, Chouaib S.

Int J Cancer. 2000 Jan 1;85(1):93-7.

17.

Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb.

Ameyar M, Shatrov V, Bouquet C, Capoulade C, Cai Z, Stancou R, Badie C, Haddada H, Chouaib S.

Oncogene. 1999 Sep 23;18(39):5464-72.

18.

High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancer.

Fernandez NC, Levraud JP, Haddada H, Perricaudet M, Kourilsky P.

J Immunol. 1999 Jan 1;162(1):609-17.

19.

Lipofectamine and related cationic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic cells.

Byk T, Haddada H, Vainchenker W, Louache F.

Hum Gene Ther. 1998 Nov 20;9(17):2493-502.

PMID:
9853516
20.

Gamma-ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells.

Morel A, Fernandez N, de La Coste A, Haddada H, Viguier M, Polla BS, Antoine B, Kahn A.

Cancer Immunol Immunother. 1998 Jul;46(5):277-82.

PMID:
9690456
22.

Thrombopoietin (TPO) knockout phenotype induced by cross-reactive antibodies against TPO following injection of mice with recombinant adenovirus encoding human TPO.

Abina MA, Tulliez M, Duffour MT, Debili N, Lacout C, Villeval JL, Wendling F, Vainchenker W, Haddada H.

J Immunol. 1998 May 1;160(9):4481-9.

23.

Does preventive vaccination with engineered tumor cells work in cancer-prone transgenic mice?

Morel A, de La Coste A, Fernandez N, Berson A, Kaybanda M, Molina T, Briand P, Haddada H, Guillet JG, Antoine B, Viguier M, Kahn A.

Cancer Gene Ther. 1998 Mar-Apr;5(2):92-100.

PMID:
9570300
24.

IL-2 gene delivery within an established murine tumor causes its regression without proliferation of preexisting antitumor-specific CTL.

Levraud JP, Duffour MT, Cordier L, Perricaudet M, Haddada H, Kourilsky P.

J Immunol. 1997 Apr 1;158(7):3335-43.

PMID:
9120291
25.

Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A.

Warnier G, Duffour MT, Uyttenhove C, Gajewski TF, Lurquin C, Haddada H, Perricaudet M, Boon T.

Int J Cancer. 1996 Jul 17;67(2):303-10.

26.

Strategies for cancer gene therapy using adenoviral vectors.

Descamps V, Duffour MT, Mathieu MC, Fernandez N, Cordier L, Abina MA, Kremer E, Perricaudet M, Haddada H.

J Mol Med (Berl). 1996 Apr;74(4):183-9. Review.

PMID:
8740649
27.

LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors.

Abina MA, Lee MG, Descamps V, Cordier L, Lopez M, Perricaudet M, Haddada H.

Gene Ther. 1996 Mar;3(3):212-6.

PMID:
8646551
28.

Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies.

Wattel E, Vanrumbeke M, Abina MA, Cambier N, Preudhomme C, Haddada H, Fenaux P.

Leukemia. 1996 Jan;10(1):171-4.

PMID:
8558924
30.

IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line.

Lamonerie T, Lavialle C, Haddada H, Brison O.

Int J Cancer. 1995 May 16;61(4):587-92.

PMID:
7759165
31.

[Application of gene therapy to antitumoral vaccination].

Fernandez N, Abina A, Descamp V, Haddada H.

Bull Cancer. 1995 Mar;82(3):228-32. French. No abstract available.

PMID:
7655158
32.

Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene.

Cordier L, Duffour MT, Sabourin JC, Lee MG, Cabannes J, Ragot T, Perricaudet M, Haddada H.

Gene Ther. 1995 Jan;2(1):16-21.

PMID:
7712329
33.

Gene therapy using adenovirus vectors.

Haddada H, Cordier L, Perricaudet M.

Curr Top Microbiol Immunol. 1995;199 ( Pt 3):297-306. Review. No abstract available.

PMID:
7555082
34.

Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice.

Haddada H, Ragot T, Cordier L, Duffour MT, Perricaudet M.

Hum Gene Ther. 1993 Dec;4(6):703-11.

PMID:
8186285
35.

Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages.

Haddada H, Lopez M, Martinache C, Ragot T, Abina MA, Perricaudet M.

Biochem Biophys Res Commun. 1993 Sep 30;195(3):1174-83.

PMID:
8216246
36.

TGF-alpha production correlates with tumorigenicity in clones of the SW613-S human colon carcinoma cell line.

Modjtahedi N, Haddada H, Lamonerie T, Lazar E, Lavialle C, Brison O.

Int J Cancer. 1992 Sep 30;52(3):483-90.

PMID:
1399125
38.

Induction of simian virus 40 transplantation immunity in hamsters by gel-purified SV40 large T antigen.

Haddada H, Le Goffic N, Chandrasekaran K, de Vaux Saint Cyr C.

Immunol Lett. 1988 Jul;18(3):225-9.

PMID:
2844659
40.
41.

Spleen cell populations in normal and tumor-bearing hamsters.

Merdrignac G, Haddada H, De Vaux Saint Cyr C, Genetet B.

Immunol Lett. 1985;10(2):81-6.

PMID:
3161821
42.

Immunologic and enzymatic studies of two breeding lines of NZB mice that differ in chromosome breakage.

Haddada H, Munsch N, de Vaux Saint Cyr C, Emerit I.

J Natl Cancer Inst. 1983 Feb;70(2):299-303.

PMID:
6600504
43.

In vivo studies of spleen lymphoid cells implicated in antitumor immunity in hamsters.

Haddada H, de Vaux Saint Cyr C, Duthu A.

Cancer Immunol Immunother. 1983;15(2):96-100.

PMID:
6307501
44.

Nude Syrian hamsters: some immunological and histological characteristics.

Haddada H, Chouroulinkov I, de Vaux Saint Cyr C.

Immunol Lett. 1982 Jun;4(6):327-33.

PMID:
6981594
45.

Evolution of DNA polymerase alpha, beta and terminal deoxynucleotidyl transferase in hamster lymphoid populations during the development of different types of tumors.

Munsch N, de Vaux Saint-Cyr C, Duthu A, Haddada H, Le Goffic N, Zuinghedau J.

Biomed Pharmacother. 1982;36(10):440-4.

PMID:
7184515
46.

Isolation of two immunoglobulin G subclasses, IgG2 and IgG1, from hamster serum using protein A-sepharose.

Escribano MJ, Haddada H, de Vaux Saint Cyr C.

J Immunol Methods. 1982;52(1):63-72.

PMID:
7119452
47.

Modifications of the lymphoid B and T cell populations in spleen and thymus of tumor-bearing hamsters.

Haddada H, de Vaux Saint Cyr C, Loisillier F, Zuinghedau J.

Adv Exp Med Biol. 1981;134:445-54. No abstract available.

PMID:
6971566
48.

[Natural cytotoxic activity in different experimental conditions in hamsters (author's transl)].

Haddada H, Duthu A, de Vaux Saint Cyr C.

Ann Immunol (Paris). 1980 Sep-Oct;131D(2):187-98. French.

PMID:
7469384
49.

Suppressive and cytostatic activities in the spleen of tumor-bearing hamsters.

Haddada H, de Vaux Saint Cyr C.

Eur J Cancer. 1980 Jun;16(6):841-8. No abstract available.

PMID:
6447607
50.

Protein A : a B cell mitogen for hamster splenic lymphoid cells.

Duthu A, Haddada H, Le Goffic N, de Vaux-Saint-Cyr C.

Dev Comp Immunol. 1980 Spring;4(2):331-9. No abstract available.

PMID:
6967431

Supplemental Content

Loading ...
Support Center